摘要：SummaryType 2 diabetes incidence continues to increase rapidly. This disease is characterized by a breakdown in blood glucose homeostasis. The impairment of glycemic control is linked to the structure of glycogen, a highly branched glucose polymer. Liver glycogen, a major controller of blood sugar, comprises small β particles which can link together to form larger α particles. These degrade to glucose more slowly than β particles, enabling a controlled release of blood glucose. The α particles in diabetic mice are however easily broken down into β particles, which degrade more quickly. Because this may lead to higher blood glucose, understanding this diabetes-associated breakdown of α-particle molecular structure may help in the development of diabetes therapeutics. We review the extraction of liver glycogen, its molecular structure, and how this structure is affected by diabetes and then use this knowledge to make postulates to guide the development of strategies to help mitigate type 2 diabetes.Graphical AbstractDisplay OmittedHighlights•Diabetes involves uncontrolled blood glucose levels•Liver glycogen acts as a blood glucose buffer•Diabetes can lead to molecularly fragile liver glycogen particles•Molecularly fragile liver glycogen may exacerbate poor blood glucose controlGlycobiology; Molecular Structure; Diabetology
